argenx SE - American Depositary Shares (NQ:ARGX)

912.39 -6.82 (-0.74%)

Delayed Quote Updated: 2:36 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Is Argenx Stock a Buy Now? ↗

July 31, 2023

Good news keeps rolling in for the biotech.

Via The Motley Fool

argenx Reports Half Year 2023 Financial Results and Provides Second Quarter Business Update

July 27, 2023

From argenx SE

Via GlobeNewswire

Earnings Outlook For argenx ↗

July 26, 2023

Via Benzinga

argenx Unusual Options Activity ↗

July 21, 2023

Via Benzinga

Why Shares of Argenx Jumped This Week ↗

July 21, 2023

The company's lead therapy showed progress in treating an autoimmune disorder.

Via The Motley Fool

Argenx Stock Rides 'Megabuster' Drug Excitement To 40% Gain Before Earnings ↗

July 26, 2023

Argenx is up around 40% in 2023 after shares soared nearly 30% in a single day last week.

Via Investor's Business Daily

argenx announces closing of global offering

July 24, 2023

From argenx SE

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

The Latest Analyst Ratings for argenx ↗

July 20, 2023

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗

July 18, 2023

Via Benzinga

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗

July 21, 2023

But all the major indexes are at or near 15-month highs.

Via Investor's Business Daily

Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade ↗

July 20, 2023

On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.

Via Investor's Business Daily

argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023

July 20, 2023

From argenx SE

Via GlobeNewswire

argenx announces full exercise of underwriters’ option to purchase additional ADSs

July 19, 2023

From argenx SE

Via GlobeNewswire

Why Argenx Stock Is on Fire Today ↗

July 17, 2023

A major clinical win is boosting the drugmaker's shares today.

Via The Motley Fool

Why Is Argenx (ARGX) Stock Up 27% Today? ↗

July 17, 2023

Argenx (ARGX) stock is climbing higher on Monday following the release of data from a Phase 1 clinical trial of VYVGART Hytrulo.

Via InvestorPlace

argenx raises $1.1 billion in gross proceeds in a global offering

July 18, 2023

From argenx SE

Via GlobeNewswire

Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development ↗

July 18, 2023

Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating...

Via Benzinga

argenx announces launch of proposed global offering

July 17, 2023

From argenx SE

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 17, 2023

Via Benzinga

argenx SE (NASDAQ: ARGX) Leading the Way in Monday Trading Based on Percentage Gain

July 17, 2023

Via Investor Brand Network

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

Argenx Catapults 27% To Record High As It Edges Closer To A New Multibillion-Dollar Market ↗

July 17, 2023

Vyvgart is already approved in multiple diseases. But Argenx isn't stopping there.

Via Investor's Business Daily

You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers ↗

July 17, 2023

Big gains are afoot even as the markets prepare for a flat open.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 17, 2023

Via Benzinga

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2023

Gainers

Via Benzinga

Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today? ↗

July 17, 2023

BYND Cannasoft Enterprise (BCAN) stock is dropping on Monday after the company announced an underwritten stock offering.

Via InvestorPlace

Why Are Argenx Shares Trading Higher Today? ↗

July 17, 2023

Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory

Via Benzinga

Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today? ↗

July 17, 2023

Quoin Pharmaceuticals (QNRX) stock is taking a massive beating on Monday as the company prepares for an ADS ratio change.

Via InvestorPlace

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.